Takara Bio Europe AB

Takara Bio Europe AB is a company in Göteborg, Sweden that has taken part in 9 EU-funded projects since 2008, receiving €6.5M in EU funding.

EU funding received€6.5M
EU projects9
As coordinator0
Running now0
First EU project2008
Latest project2012
CountrySweden
EU registration (PIC)998937623
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Takara Bio Europe AB's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€6.5M · 9 projects

Projects

9 EU-funded projects, newest first. Each links to the official record.

  • NANOBIO4TRANSPartner

    A new nanotechnology-based paradigm for engineering vascularised liver tissue for transplantation

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €1.3Mtheir share
  • MIP-DILIPartner

    Mechanism-Based Integrated Systems for the Prediction of Drug-Induced Liver Injury

    FP7 (2007 to 2013) · 2012–2017 · Project on CORDIS ↗

    €927ktheir share
  • TissueGENPartner

    THE PRODUCTION OF A 3D HUMAN TISSUE DISEASE PLATFORM TO ENABLE REGENERATIVE MEDICINE THERAPY DEVELOPMENT

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €1.2Mtheir share
  • CARDIONETPartner

    Translational Training network on the Cellular and Molecular Bases of Heart Homeostasis and Repair

    FP7 (2007 to 2013) · 2012–2015 · Project on CORDIS ↗

    €100ktheir share
  • 4DCELLFATEPartner

    Developing a global understanding of the PRC and NuRD complexes in stem cell differentiation, in health and disease

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €41ktheir share
  • InnovaLivPartner

    Innovative strategies to generate human hepatocytes for treatment ofmetabolic Liver diseases: Tools for personalized cell therapy

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €1.4Mtheir share
  • SCR&TOXPartner

    Stem Cells for Relevant Efficient Extended and Normalized Toxicology

    FP7 (2007 to 2013) · 2011–2015 · Project on CORDIS ↗

    €612ktheir share
  • HYPERLABPartner

    High yield and performance stem cell lab

    FP7 (2007 to 2013) · 2009–2012 · Project on CORDIS ↗

    €363ktheir share
  • ESNATSPartner

    Embryonic Stem cell-based Novel Alternative Testing Strategies

    FP7 (2007 to 2013) · 2008–2013 · Project on CORDIS ↗

    €486ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • adverse drug reactions
  • automation
  • bioartificial liver
  • biomaterials
  • bioreactors
  • cell biology
  • drug discovery
  • electron microscopy
  • hepatology
  • homeostasis
  • mass spectrometry
  • nucleic acids
  • pharmaceutical drugs
  • proteomics

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime